Navigation Links
Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
Date:11/5/2008

oking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development, manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(R) (lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products, including, but not limited to, the impact of those on the Company's ADHD franchise; patents, including but not limited to, legal challenges relating to the Company's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); the Company's ability to secure new products for commercialization and/or development; the Company's ability to successfully integrate its stake in Jerini AG, as well as realize the anticipated benefits of the acquisition; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2007.

For further information please contact:

Investor Cléa Rosenfeld (Rest of the World) +44-1256-894-160

Relations

Eric Rojas (North America) +1-617-551-9715

Media Jessica Mann (Rest of the World) +44-1256-894-280

Matthew Cabrey (North America) +1-484-595-8248

Jessica Cotrone (North America) +1-617-613-4640


'/>"/>
SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... Where is the universe expanding to? ... honest answer is that nobody is entirely sure." , ... the month of June, starting with the ULI Florida ... to top tech trends. And one of the most ... universe is expanding to. According to Einstein’s theory of ...
(Date:5/25/2015)... Israel (PRWEB) May 25, 2015 Phenome ... software provider, announced the availability, beginning May 31st, ... new version of Phenome One solidifies Phenome Networks’ lead ... interface supporting a simple and intuitive breeding workflow based ... the ability to customize field design, and more. The ...
(Date:5/22/2015)... , May 22, 2015 According ... Product (1D & 2D Gel Electrophoresis, Agarose & Polyacrylamide ... Reagents, Informatics), by Application & by End User - ... Market is expected to reach around $1.98 Billion by ... period 2015 to 2020. Browse 226 ...
(Date:5/22/2015)... Knowledgent , the data and analytics firm, ... of big data analytics in the life sciences and ... life sciences and healthcare organizations understand the ways in ... insights. , The life sciences and healthcare industries historically ... profiling, compliance and regulatory requirements, and scientific research. These ...
Breaking Biology Technology:Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 2Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 3Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 2Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 3Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2
... CRANBURY, N.J., April 24 Amicus Therapeutics,Inc. (Nasdaq: ... and,Chief Executive Officer, will present a corporate update at ... 30,2008, at 2:20 p.m. EDT, at the Ritz-Carlton in ... live and may be accessed by visiting,Amicus, website at ...
... announced it will release its fiscal 2008 second quarter,results for the ... market closes. Senior management will host a live webcast and,conference call ... Time., What: Plexus Corp.,s ... Thursday, April 24th at 8:30 a.m. Eastern Time, ...
... Germany, April 24, 2008 / b3c newswire / ... Stanford University are working on a project to synthesize ... in a statistically expected and controlled ratio at preselected ... utilize its core technology, Slonomics™, a unique DNA engineering ...
Cached Biology Technology:Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T. 2Sloning and the Kornberg group at Stanford University starting evaluation project regarding the synthesis of a Statistically Randomized Gene Library 2
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, reminds investors ... Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA ... 5-7, 2015. The three-day conference is organized ... is speaking in is themed Global Fraud: Where is ...
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:4/13/2015)... YORK , April 13, 2015 ... by TechSci Research, "Global Biometrics Market Forecast & Opportunities, ... register a CAGR of around 14% till 2020. ... governments for large scale implementation and review of ... and launch of new products with greater efficiency, ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... Engineering researchers the University of Southern California have made ... the construction of a synthetic brain. They have built ... reproduces the function of a neuron, the building block ... by Professor Alice Parker and Professor Chongwu Zhou in ...
... rearrangements in roundworm chromosomes may offer new insight into large-scale ... of the research led by University of North Carolina at ... April 22 online edition of the journal Science . ... sequence that protects the ends of chromosomes from deterioration or ...
... how a single-celled fungus survives in low-oxygen settings may ... organ transplants or AIDS. A report on the ... 22 in Molecular Cell . Previous work ... model organism that,s often used to study individual genes, ...
Cached Biology News:Researchers create functioning synapse using carbon nanotubes 2Study in roundworm chromosomes may offer new clues to tumor genome development 2Simple fungus reveals clue to immune system protection 2
With sodium bicarbonate. Sterile, Cell culture tested...
... Easy and Cost effective - Utilizes hands-off homogenization ... , No grinding - Extract DNA without ... tools between samples , Robust tubes ... and homogenize without tube breakage , ...
Imject Freund's Complete Adjuvant (FCA)...
The Synergy HT utilizes a unique dual-optics design combined with monochromator wavelength selection to provide uncompromised performance in absorbance, fluorescence and luminescence reading modes. ...
Biology Products: